InvestorsHub Logo
Followers 556
Posts 17434
Boards Moderated 42
Alias Born 10/21/2003

Re: Bobwins post# 144891

Wednesday, 06/06/2012 1:05:37 PM

Wednesday, June 06, 2012 1:05:37 PM

Post# of 173714
CEMID +.05 to $4.55

MEDFORD, N.Y. (June 6, 2012) -- Chembio Diagnostics, Inc. (OTCQB:CEMI.PK)(CEMI.PK), which develops, manufactures, markets and licenses point-of-care diagnostic tests, announced today that its common stock will commence trading on the NASDAQ Capital Market® on Thursday, June 7, 2012, under the ticker symbol "CEMI". Prior to the listing change to NASDAQ, the company's common stock will continue to trade on the OTC Bulletin Board under the current ticker symbol "CEMID”.
Lawrence Siebert, Chief Executive Officer of Chembio, commented, “We are pleased that NASDAQ has confirmed that Chembio has met all of their eligibility requirements. We are confident that this NASDAQ Capital Market® listing will provide Chembio with a significantly expanded market for its securities, generating increased investor interest, which our Board of Directors believes will be in the best interest of all of our shareholders.”

Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.

If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.